Cargando…

469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017

BACKGROUND: Recently, overall reductions for invasive MRSA infections (isolation from a normally sterile site) have slowed. Healthcare-associated community-onset (HACO) invasive methicillin-resistant Staphylococcus aureus (MRSA) infections are those with recent healthcare exposures who develop MRSA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Kelly A, Gokhale, Runa Hatti, Nadle, Joelle, Petit, Susan, Ray, Susan, Harrison, Lee, Lynfield, Ruth, Dumyati, Ghinwa, Schaffner, William, See, Isaac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809088/ http://dx.doi.org/10.1093/ofid/ofz360.542

Ejemplares similares

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19
por: Biggs, Holly, et al.
Publicado: (2023)

1443. Characteristics of nursing homes with higher rates of invasive methicillin-resistant Staphylococcus aureus infections
por: See, Isaac, et al.
Publicado: (2023)

1211. Increasing Incidence of Invasive Methicillin-Resistant and Methicillin-Sensitive S. aureus Infections Among Persons Who Inject Drugs, 2014–2017
por: Felsen, Christina B, et al.
Publicado: (2018)

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020
por: Jackson, Kelly, et al.
Publicado: (2023)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
por: Jackson, Kelly A, et al.
Publicado: (2023)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
por: Rha, Brian, et al.
Publicado: (2023)

887 Opportunities to Improve Completeness of MRSA Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network
por: Nguyen, Duc, et al.
Publicado: (2014)

Community-associated Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors
por: Klevens, R. Monina, et al.
Publicado: (2006)

468. Epidemiologic Features of Invasive Methicillin-Resistant Staphylococcus aureus and Group A Streptococcus Infections among Adults Who Inject Drugs in the San Francisco Bay Area, 2008–2017
por: Nadle, Joelle, et al.
Publicado: (2019)

111. Pediatric and Adolescent Sepsis Epidemiology and Clinical Characteristics, Emerging Infections Program, 2014–2015
por: Gokhale, Runa Hatti, et al.
Publicado: (2019)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA
por: Koeck, Mackenzie, et al.
Publicado: (2019)

Bacterial and Fungal Infections in Persons Who Inject Drugs — Western New York, 2017
por: Hartnett, Kathleen P., et al.
Publicado: (2019)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

Trends in Invasive Infection with Methicillin-Resistant Staphylococcus aureus, Connecticut, USA, 2001–2010
por: Hadler, James L., et al.
Publicado: (2012)

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
por: Magill, Shelley S., et al.
Publicado: (2015)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

1831. Point Prevalence and Epidemiology of Antimicrobial Use in US Nursing Homes, 2017
por: Thompson, Nicola D, et al.
Publicado: (2018)

An Outbreak of Community-Acquired Foodborne Illness Caused by Methicillin-Resistant Staphylococcus aureus
por: Jones, Timothy F., et al.
Publicado: (2002)

Methicillin-Resistant Staphylococcus aureus at Canoe Camp
por: Como-Sabetti, Kathryn, et al.
Publicado: (2006)

Systematic review of antibiotic stewardship interventions for urinary tract infection management in the ambulatory setting
por: Munsiff, Sonal, et al.
Publicado: (2022)

Hospital-Nursing Home Transfer Patterns and Influence on Nursing Home Clostridium difficile Infection Rates
por: Campbell, Lauren, et al.
Publicado: (2017)

469 The Relationship between Vancomycin Minimum Inhibitory Concentrations (MICs) and Treatment Failure among Patients with Methicillin-Resistant Staphylococcus aureus Blood Stream Infections (MRSA-BSI) at the University of Connecticut Health Center (UCHC)
por: Gemtessa, Tilahun Amdissa, et al.
Publicado: (2014)

115 Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI)
por: Phipps, Erin C., et al.
Publicado: (2014)

Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015–2017
por: Parikh, Meghana P., et al.
Publicado: (2020)

Community-associated Methicillin-resistant Staphylococcus aureus Isolates and Healthcare-Associated Infections
por: Maree, Cynthia L., et al.
Publicado: (2007)

Answer to the question from page 469
Publicado: (2013)

Similar Clinical Severity and Outcomes for Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Pediatric Musculoskeletal Infections
por: An, Thomas J., et al.
Publicado: (2017)

Methicillin-resistant Staphylococcus aureus Skin Infections
por: Ma, Jui-Shan
Publicado: (2005)

Revisiting Methicillin-Resistant Staphylococcus aureus Infections
por: Waness, Abdelkarim
Publicado: (2010)

Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock
por: Fay, Katherine, et al.
Publicado: (2020)

1105. Statewide, Retrospective, Cohort Study of Medicare Part B Quinolone Prescribing for Cystitis in 2016–2017
por: Yu, Joyce, et al.
Publicado: (2019)

Emerging Infections Program—20 Years of Achievements and Future Prospects
por: Lynfield, Ruth, et al.
Publicado: (2015)

1424. Factors Associated with Failure to Clear Candidemia Infection: Surveillance Data from Eight States, 2017
por: Oh, David H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f5ckiog998evavol5pj1n44m2h